
3ã¶æä»¥äžç¶ãè ã®çã¿ãæå ã®ãã³ãïœã¯ã¯ãã³èª€æ³šå ¥ã«ããSIRVAã®äºäŸïœ
ååŽçã®ãµã€ãã§å ¬éãããŠãããæ°åã³ããã¯ã¯ãã³æ¥çš®åŸã®å¯åå¿çãå ±åãã«ãSIRVAãšèšºæããã人ãããŸããã倧æã¡ãã£ã¢ãªã©ã§ã¯åãäžããªãã®ã§ãç§ã¯åããŠç¥ããŸããããå®ã¯åæ§ã®çç¶ã«æ©ãŸãããŠãã人ã¯å€ãã®ã§ã¯ãªãã§ããããã
ã¯ã¯ãã³èª€æ³šå ¥ã«ããè ã®çã¿ãšãã³ã
æ¥çš®ããè ã«éã ãã匷ãçã¿ãšãèããæå ã®ãã³ããç¶ããSIRVA(Shoulder injury related vaccine administration)ãšèšºæãããäºäŸã§ãã
ååŽçãµã€ããããŒã > æ¿çã«ã€ããŠ> 審è°äŒã»ç ç©¶äŒç> åçç§åŠå¯©è°äŒ(äºé²æ¥çš®ã»ã¯ã¯ãã³åç§äŒ å¯åå¿æ€èšéšäŒ)> 第76ååçç§åŠå¯©è°äŒäºé²æ¥çš®ã»ã¯ã¯ãã³åç§äŒå¯åå¿æ€èšéšäŒã什åïŒå¹ŽåºŠç¬¬28åè¬äºã»é£åè¡ç審è°äŒè¬äºåç§äŒå»è¬åçå®å šå¯ŸçéšäŒå®å šå¯Ÿç調æ»äŒïŒååéå¬ïŒè³æã2æ18æ¥
è³æ1ïŒ2ïŒ3ïŒ1ããã
玹ä»ããå ±åã¯ãéè€ããŠããéšåãªã©ã¯ç·šéããŠãããŸããBNT162b2ã¯ãã³ãããã£ç泚ïŒãã¡ã€ã¶ãŒè£œïŒã®ããšã§ããæç³»åã§è¿œããããã«ãé çªãå
¥ãæ¿ãããããŠããŸãã
â»ã¯ããã¡ãã§è£è¶³ããŸããã
äºäŸïŒ17231ã48æ³å¥³æ§ãã³ãããã£ç泚1åç®æ¥çš®ããããçªå·ïŒFF5357
é¢é£ããç æŽã¯ãªãã£ããã¯ã¯ãã³ã®äºèšºç¥šã§ã®çæç¹ã¯ãªãã£ãã
èšåºçµéïŒ
2021/09/10 17:00ïŒã¯ã¯ãã³æ¥çš®ã® 6 æéåŸïŒãSILVA(Shoulder
injury related vaccine administration)ãçºçŸãããïŒâ»SIRVAã®ééãïŒïŒ
äºè±¡ã®çµéã¯ä»¥äžã®éãã§ãã£ãïŒ
2021/09/10 11:00ã å·Šäžè ã« 2 åç®ïŒâ»1åç®ã®ééãïŒïŒã® COVID-19 ã¯ã¯ãã³æ¥çš®ãåãããæ¥çš®æã«ç¥çµé害ãçããããªçŒçãšããœãŒãã¯ãªãã忥倿¹ãããäžè ã®çã¿ããã
2021/09/11ã2021/09/12 ã¯çºç±ãããçºç±ã®ãããããã§å¯èŸŒãã§ãããäžè åšå²ã®çã¿ã¯æç¶ããŠããã
2021/09/13 è§£ç±åŸãæ¥åžžç掻ãéãäžã§ãå·Šäžè¢å šäœã®éã ãã匷ãçã¿ãšãå·Šèããæå ã®ãã³ããèªèŠããã
2021/09/21 ã«çåäœäžãããé£åšãå²ãäžå®ã«ãªã£ãã
2021/09/22 è¿å»è³ç¥çµå€ç§å蚺ãããé éšãšé æ€ MRIïŒç£æ°å ±é³Žç»åïŒæ®åœ±ãããç°åžžç¡ããçç¶ç¶ããããè¿å»ç¥çµå ç§å蚺ããããç°åžžç¡ãã
2021/10/29 åœé¢å蚺ãšãªã£ããæ¡åïŒå³è 26kgãå·Šè 17kgãéåžžäžè ã§ã®çèæ³šå°ã§åé¡ãšãªãæ©éªšç¥çµãè 窩ç¥çµã«ã¯ç¥èŠäœäžãªã©ç¥çµé害ãçãæèŠãªããè©é¢ç¯å¯ååå¶éã¯å€è»¢ 160 床ãšè»œåºŠã®ã¿ããã€ã³ãã«ã¢ãŒã¯ã¯éœæ§ãçµéãã SILVA(Shoulder injury related vaccine administration)ã®èšºæãšãªã£ããçŒçæç¶ãããããè©ã® MRI æ®åœ±ãããäžè§çãšæ£äžçã®éã«ççæèŠãããã¯ã¯ãã³æäžé¢é£è©æå·ã®ããã«æ²»ççãªåŠçœ®ã¯è¡ãããªãã£ãã
2021/09/13 äºè±¡ã®çºç±ã®è»¢åž°ã¯å埩ã§ãã£ãã
2021/12/28ïŒã¯ã¯ãã³æ¥çš®ã® 109 æ¥åŸïŒãä»ã®å šãŠã®äºè±¡ã®è»¢åž°ã¯æªå埩ã§ãã£ãã
å ±åå»åž«ã¯ãäºè±¡ãé節ãšåé¡ããäºè±¡ã¯ BNT162b2 ãšé¢é£ãããšè©äŸ¡ãããä»èŠå ïŒä»ã®çŸæ£çïŒã®å¯èœæ§ã¯ãªãã£ãã
å ±åå»åž«ã¯ã以äžã®éãã«ã³ã¡ã³ãããïŒCOVID-19 ã¯ã¯ãã³ã®æ¥çš®åŸããã®çç¶ã§ãããã¯ã¯ãã³ãè©å³°äžæ»æ¶²å ã«èª€æ³šå ¥ãããããšã«äŒŽã SILVA(Shoulder injury related vaccine administration)ãšèããŠããã
MRI ã§ãåéšäœã«ççæèŠãèªããè©é¢ç¯åšå²çã®ç¶æ ã§ãããå¯ååå¶éã軜床ã®ããã«ãããªã匷ãçŒçãç¶ããŠãããSILVA(Shoulder injury related vaccine administration)ã§ããã°ãæ°ã¶æã§è»œæžãããšèããŠããããçŸåšããªããªãé®çãåŸãããŠããªããçŒçãç¶ããšãåçµè©ïŒâ»è©ãåºãŸã£ãŠåããªããªãçç¶ïŒã«ç§»è¡ãããªã¹ã¯ããããšèããŠããã
SIRVAãªãæ°ã¶æã§è»œæžãããšèšã£ãŠããŸããããã®æ¹ã¯ãã§ã«4ã¶æè¿ãçç¶ãç¶ããŠããŸãã
SIRVA(Shoulder injury related vaccine administration)ãšã¯ïŒ
ååŽçãªã©ãå ¬çæ©é¢ã®ãµã€ãã§æ å ±ãèŠã€ããããšã¯ã§ããŸããã§ãããããSIRVAãã¯ã¯ãã³ãèª€æ³šå ¥ããªã©ã§æ€çŽ¢ãããšå¯Ÿå¿ããŠããå»çæ©é¢ãªã©ã«æ å ±ããããŸããåæã«ãªã³ã¯ããŠãããããããªãã®ã§ãªã³ã¯ããŸããããããå»çæ©é¢ã®ããã°ã«ã¯ãæ°åã³ããã¯ã¯ãã³æ¥çš®ãå§ãŸã£ãæ©ãææã«SIRVAã®ããšãæžãããŠãããã³ã¡ã³ãæ¬ã«ã¯SIRVAãããããªãæ¹ãã¡ãããå€ãã®çžè«ãå¯ããããŠããŸããã
CDCïŒã¢ã¡ãªã«çŸç
äºé²ç®¡çã»ã³ã¿ãŒïŒã®è³æã«ã¯ãäžèšã®ããã«æžãããŠããŸãã
Shoulder Injury Related to Vaccine Administration
âShoulder injury related to vaccine administration (SIRVA) was added to the Vaccine Injury Compensation Table in March 2017
âShoulder injuries related to vaccine administration are injuries to the musculoskeletal structure of the shoulder, including the ligaments, bursa, and tendons
ã⢠They are thought to occur as a result of the unintended injection of vaccine antigen and/or trauma from the needle going into and around the underlying bursa of the shoulder
ã⢠Symptoms include shoulder pain and limited mobility after the injection
ïŒSIVRAã¯ã2017幎3æã«Vaccine Injury Compensation TableïŒâ»ïŒã«è¿œå ããããéåž¯ãæ»æ¶²å ãè ±ãªã©ãè©ã®çéªšæ Œç³»æ§é ã®å·å®³ã«ãã£ãŠåŒãèµ·ãããããè©ã®æ»æ¶²å ããã®åšèŸºãžã®ã¯ã¯ãã³ã®èª€æ³šå ¥ã«ããçºçãããšèããããŠãããæ¥çš®åŸã«ãè©ã®çã¿ãå¯ååã®å¶éãªã©ã®çç¶ãåºãïŒ
â»Vaccine Injury Compensation Tableã¯ãã¢ã¡ãªã«ã®ã¯ã¯ãã³å¥åº·è¢«å®³è£åããã°ã©ã ïŒVICP:Vaccine Injury Compensation ProgramïŒã®å¯Ÿè±¡ãšãªãçç¶ãçºçŸãŸã§ã®æéãæžããã衚ã®ããã§ããååŽçã®è³æã«ãæ¥æ¬ãšã®æ¯èŒããããŸããã

Vaccine Injury Tableã«è©²åœããå Žåã¯ãå³å¯ãªå»åŠçå æé¢ä¿ã®ç«èšŒãæ±ããã«éããã«è£åãããä»çµã¿ãšãªã£ãŠãããè¿ éãªææžãå¯èœãšããŠã
ãããªããTableã«è©²åœããªãå Žåã¯è«æ±è ãç«èšŒè²¬ä»»ãè² ãã
Vaccine Injury Tableã«ãããšãSIRVAã«è©²åœããåºæºãšããŠããäºåã«æ£éšã®è©ã«çã¿ãççãæ©èœé害ãªã©ã®æ¢åŸæŽã¯ãªãããã¯ã¯ãã³æ³šå°åŸã«çºçããæ€æ»æèŠããªã©ããããŸããã¯ã¯ãã³ããšã«çºçŸãŸã§ã®æéãæ±ºããããŠããŠããããè¶ãããšèªå®ãããªãããã§ãã
远èšïŒäžèšããªã³ã¯åããšãªãã2022幎çã«ãªã£ãŠããŸããã
https://www.hrsa.gov/sites/default/files/hrsa/vicp/vaccine-injury-table-01-03-2022.pdf
äŸãã°HPVã¯ã¯ãã³ã®å ŽåãSIRVAã¯ã48æé以å ã®çºçŸããšãªã£ãŠããããã§ãããæ°åã³ããã¯ã¯ãã³ã«ã€ããŠã¯æžãããŠããŸãããæ°åã³ããã¯ã¯ãã³ã¯ãVICPã®å¯Ÿè±¡ã«ã¯ãªã£ãŠãããã代ããã®CICPïŒCountermeasures Injury Compensation ProgramïŒã«ã¯å¯Ÿè±¡å·å®³ã®å ¬åŒãªè¡šã¯ãŸã ãªãããã§ãã
ä»åŸãæ¥æ¬ã§SIRVAãææžã®å¯Ÿè±¡ãšãªããããããŸããããèª€æ³šå ¥ãããªãããã«ã¯ãæ£ããäœçœ®ãç¥ã£ãŠããå¿ èŠãããããã§ãã
å¥è¯çç«å»ç§å€§åŠãæŽåœ¢å€ç§ã»èšåºç ä¿®ã»ã³ã¿ãŒã®ãµã€ãã«ããçèæ³šå°ããã¥ã¢ã«(v1.7)ããå ¬éãããŠããŸããPDFãžã®çŽæ¥ãªã³ã¯ã¯é¿ããããã«ãšã®ããšãªã®ã§ãéãåºãäœçœ®ãè§åºŠãªã©ã¯äžèšã®ããŒãžããããã¥ã¢ã«ããã§ãã¯ããŠã¿ãŠãã ããããã¬ããªã©ã§èŠããšãããããé«ãäœçœ®ã«æ¥çš®ããŠããããã«æããŸãã
æ°åã³ããã¯ã¯ãã³ã®é壿¥çš®äŒå Žãªã©ã§ã¯ãçèæ³šå°ã«æ
£ããŠããªãå»åž«ããããšæãããŸãããã誀泚å
¥ã®ããã§çã¿ãèµ·ããŠãã人ãå€ããããªããæ¥çš®ããå»åž«ãã¡ã«ãã£ãšæ³šæåèµ·ããããæ¥çš®åŸã®çç¶ã蚺ãå»åž«ãã¡ã«SIRVAã®å¯èœæ§ãåšç¥ããå¿
èŠãããã®ã§ã¯ãªãã§ããããããã¡ããšèšºæãããªãã£ãããæ²»çã«ãã£ãŠçã¿ã¯ãªããªã£ãããã©ããªãã®æ²»çè²»ãããã£ããšããæ¹ãå°ãªããªãããã§ãã
2014幎ã«èµ·ããäºäŸãšããŠããå»åž«ãåå®®é žããäºé²ã¯ã¯ãã³ã驿£äœçœ®ããé«ãäœçœ®ã«æ³šå°ããé倱ã«ãããæ£è
ã«å·Šè©é¢ç¯çãçºçãåžç«ç
é¢åŽã«æå®³è³ åãåœããå°è£å€æ±ºããšããèšäºããããŸããã
ãããããããæ°åã³ããã¯ã¯ãã³ã§ãããã®ãããªè£å€ãèµ·ããŠããããããªããããªäºäŸãããããããã®ã§ã¯ãªãã§ããããã